Xiaofeng Dai
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Oncology top 2%
- Cancer Cells and Metastasis
Papers in
-
- RNA modifications and cancer 15
- Heme Oxygenase-1 and Carbon Monoxide 10
- Bioinformatics and Genomic Networks 10
- Gene expression and cancer classification 8
-
- Cancer-related molecular mechanisms research 10
- Cancer, Hypoxia, and Metabolism 8
- Co-authors
- Zhonghu Bai (10 shared papers)Hongye Cheng (4 shared papers)Jia Li (2 shared papers)Li Shen (2 shared papers)Kostya Ostrikov (17 shared papers)Xiuxia Liu (8 shared papers)Yankun Yang (9 shared papers)Jinling Zhan (2 shared papers)
- Journals
- Scientific Reports (6 papers)Frontiers in Oncology (5 papers)International Journal of Biological Sciences (5 papers)Journal of Cancer (5 papers)Virulence (3 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Xiaofeng Dai
145 papers receiving 5.1k citations
Xiaofeng Dai's Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 968
- Oncology 896
- Molecular Biology 2.3k
- Radiology, Nuclear Medicine and Imaging 667
- Immunology 286
Countries citing papers authored by Xiaofeng Dai
This map shows the geographic impact of Xiaofeng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Dai more than expected).
Fields of papers citing papers by Xiaofeng Dai
This network shows the impact of papers produced by Xiaofeng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Dai. The network helps show where Xiaofeng Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaofeng Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping Hit paper breakdown → | 2017 | 814 |
| 2 | Breast cancer intrinsic subtype classification, clinical use and future trends. Hit paper breakdown → | 2015 | 731 |
| 3 | 2016 | 319 | |
| 4 | Advances and Trends in Omics Technology Development Hit paper breakdown → | 2022 | 284 |
| 5 | 2021 | 135 | |
| 6 | Lactate, histone lactylation and cancer hallmarks Hit paper breakdown → | 2023 | 133 |
| 7 | 2018 | 120 | |
| 8 | 2018 | 107 | |
| 9 | 2021 | 106 | |
| 10 | 2020 | 81 | |
| 11 | 2019 | 77 | |
| 12 | 2020 | 75 | |
| 13 | 2014 | 65 | |
| 14 | 2020 | 62 | |
| 15 | 2021 | 58 | |
| 16 | 2021 | 54 | |
| 17 | 2021 | 52 | |
| 18 | 2019 | 51 | |
| 19 | 2015 | 48 | |
| 20 | 2020 | 47 |
About Xiaofeng Dai
Xiaofeng Dai is a scholar working on Molecular Biology, Cancer Research, Oncology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, having authored 148 papers that have together received 5.2k indexed citations. Recurring topics across this work include Plasma Applications and Diagnostics (16 papers), RNA modifications and cancer (15 papers), Heme Oxygenase-1 and Carbon Monoxide (10 papers), Cancer-related molecular mechanisms research (10 papers), Bioinformatics and Genomic Networks (10 papers), Nanoplatforms for cancer theranostics (9 papers), Gene expression and cancer classification (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). The work is most often cited by research in Cancer Research (968 citations), Oncology (896 citations), Molecular Biology (2.3k citations), Radiology, Nuclear Medicine and Imaging (667 citations) and Immunology (286 citations). Xiaofeng Dai has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Zhonghu Bai, Hongye Cheng, Jia Li, Li Shen, Kostya Ostrikov, Xiuxia Liu, Yankun Yang, Jinling Zhan, Ting Li and Bozhi Shi. Their work appears in journals such as Scientific Reports, Frontiers in Oncology, International Journal of Biological Sciences, Journal of Cancer and Virulence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.